Lei Lei Wu - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Lei Lei Wu's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayLei Lei Wu
Verified
News Reporter, Endpoints News
New Jersey, Princeton Junction
Beats
fitness and wellness
Content
By Lei Lei Wu Verified| Endpoints News Verified Several small clinical trials have demonstrated that gene therapies have restored hearing in children with a rare form of genetic deafness. In an update at …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
By Lei Lei Wu Verified| Endpoints News Verified To Candel Therapeutics CEO Paul Peter Tak, the biotech’s viral immunotherapy has passed the “bloody obvious test” in pancreatic cancer, and it’s preparing to start …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
By Lei Lei Wu Verified| Endpoints News Verified Several small clinical trials have demonstrated that gene therapies have restored hearing in children with a rare form of genetic deafness. In an update at …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Company Info
Endpoints News
Endpoints News is an independent news organization dedicated to the biopharmaceutical industry. Founded in 2016 by Arsalan Arif and John Carroll, it has established itself as a trusted source of information, boasting over 163,000 subscribers, including executives and scientific leaders from top pharmaceutical companies and biotech startups worldwide. The organization provides daily news reports, analysis, and events tailored for biopharma professionals. Its offerings include daily newsletters like the Early Edition, investigative reporting on drug development and regulatory updates, and in-person and virtual conferences such as the Endpoints Summit. Endpoints News emphasizes independent journalism and operates on a subscription model, providing premium content to subscribers while maintaining ad-free reporting. With a focus on both scientific and business aspects of the industry, it serves decision-makers across the global pharmaceutical landscape.
Lawrence, Kansas, United States
+1 785-813-1733
Founded: 2014